Dan Belmont

Title: The Innovative Journey of Dan Belmont

Introduction: Dan Belmont, a distinguished inventor based in Boston, MA, is known for his remarkable contributions to the field of pharmaceutical chemistry. With a total of five patents to his name, Belmont has played a pivotal role in developing methods and compounds that advance medical treatments.

Latest Patents: Among his latest innovations, Dan Belmont has patented methods of synthesizing the pharmacological agent known as 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate, commonly referred to as CV-8972. This invention outlines detailed processes for chemical synthesis that avoid creating a salt form of the compound during the formation of a free base intermediate, CV-8814. Additionally, he has developed new crystal forms of this compound, providing polymorphs that can enhance the effectiveness of pharmaceutical compositions and offer improved methods for treating various medical conditions.

Career Highlights: Throughout his career, Belmont has consistently pushed the boundaries of pharmaceutical innovation. His dedication to research and development has led to significant improvements in drug formulations. His work not only contributes to scientific knowledge but also has the potential to impact patient care positively.

Collaborations: At Imbria Pharmaceuticals, Inc., where Belmont works, he collaborates with talented colleagues, including Neil Buckley and Sarah Bethune. These partnerships foster an environment of creativity and innovation, enabling the team to tackle complex challenges in drug development effectively.

Conclusion: Dan Belmont exemplifies what it means to be an inventor in today's fast-paced pharmaceutical industry. Through his patents and collaborations, he continues to drive innovations that may greatly benefit medical science and patient outcomes. His work at Imbria Pharmaceuticals reflects his commitment to advancing healthcare through inventive solutions.